- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00225732
Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients
May 17, 2016 updated by: Cumberland Pharmaceuticals
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Injection (IVIb) for Treatment of Pain in the Post-Operative Adult Patients
The primary objective of this study of Caldolor (IV ibuprofen) administered to post-operative hospitalized adult patients every 6 hours for 48 hours is to determine the efficacy of Caldolor compared to placebo for the treatment of post-operative pain as measured by reduction in the requirement for the narcotic analgesic, morphine, post surgery
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
319
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Adelaide, Australia, 5000
- Royal Adelaide Hospital
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- Cooper Green Hospital / Jefferson Clinic
-
Birmingham, Alabama, United States, 35235
- Medical Center East / Alabama Clinical Therapeutics
-
Mobile, Alabama, United States, 36608
- Springhill Hospital / Wilmax Clinical Research, Inc.
-
Mobile, Alabama, United States, 36652-2144
- Mobile Infirmary Medical Center / Wilmax Clinical Research, Inc.
-
Montgomery, Alabama, United States, 36106
- Jackson Hospital / Drug Research and Analysis Corporation
-
Montgomery, Alabama, United States, 36111
- Baptist Medical Center South / Drug Research and Analysis Corporation
-
-
Arizona
-
Phoenix, Arizona, United States, 85023
- Arizona Research Center
-
-
California
-
Colton, California, United States, 92324
- Valley OB/GYN
-
-
Kansas
-
Wichita, Kansas, United States, 67208
- Research Support Personnel LLC
-
-
Kentucky
-
Lexington, Kentucky, United States, 40536
- Chandler Medical Center; Ken Muse Research
-
-
Tennessee
-
Hendersonville, Tennessee, United States, 37075
- Comprehensive Pain Specialists
-
-
Texas
-
Fort Worth, Texas, United States, 76135
- Health First Medical Group
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Scheduled for elective abdominal hysterectomy surgery with anticipated need for post-operative I.V. morphine analgesia with anticipated use of ≥ 24 hours.
- Adequate IV access
- Anticipated hospital stay ≥ 24 hours
Exclusion Criteria:
- Be unable to make a reliable self-report of pain intensity to pain relief
- Less than 18 years of age
- Greater than 70 years of age
- Use of NSAIDs within 12 hours prior to dosing
- Use of analgesics, muscle relaxants and sedatives less than 24 hours prior to CTM administration with the following exceptions: paracetamol (acetaminophen) can be administered until 6 hours prior to surgery; tramadol can be administered until midnight the evening prior to surgery; muscle relaxants working at the neuromuscular junction used for intubation and/or anesthesia administration for the surgical procedure prior to CTM administration; and sedatives (i.e., midazolam) used as a co-induction agent for the surgical procedure prior to CTM administration
- Patients taking warfarin, lithium, combination of ACE-inhibitors and furosemide
- Patients with anemia (active clinically significant) and/or a history or evidence of asthma or heart failure
- History of allergy or hypersensitivity to any component of Caldolor, aspirin (or aspirin related products), NSAIDs, or COX-2 inhibitors
- Pregnant or nursing
- History of severe head trauma that required current hospitalization, intracranial surgery or stroke within the previous 30 days, or any history of intracerebral arteriovenous malformation, cerebral aneurysm or CNS mass lesion
- Weigh less than 30kg
- Have a history of congenital bleeding diathesis (eg hemophilia) or any active clinically significant bleeding, or have underlying platelet dysfunction including (but not limited to) idiopathic thrombocytopenic purpura, disseminated intravascular coagulation, or congenital platelet dysfunction
- Have GI bleeding that required medical intervention within the previous 6 weeks (unless definitive surgery has been performed)
- Have a platelet count less than 30,000mm3 determined within the 28 days prior to surgery
- Pre-existing dependence on narcotics or known tolerance to opioids
- Inability to understand the requirements of the study, be willing to provide written informed consent (as evidenced by signature on an informed consent document approved by an Institutional Review Board [IRB]), and agree to abide by the study restrictions and to return for the required assessments
- Refusal to provide written authorization for use and disclosure of protected health information
- Be on dialysis, have oliguria or calculated creatinine clearance of less than 60 mL/min (calculated using the Cockcroft and Gault formula) determined within the 28 days prior to surgery
- Inability to achieve hemostasis or inability to close surgical incision, prior to Operating Room discharge
- Operative procedure includes organ transplant
- Pre or intra-operative procedure utilized for the prevention of pre- or post-operative pain (i.e. epidural or nerve blocks)
- Be receiving full dose anticoagulation therapy or Activated Protein C within 6 hours before dosing (Prophylaxis with subcutaneous heparin is acceptable)
- Have received another investigational drug within the past 30 days
- Be otherwise unsuitable for the study in the opinion of the investigator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: normal saline
|
250 ml normal saline as a placebo comparator was administered every 6 hours for a total of eight doses over the first 48 hours.
Those patients who received the initial eight doses could continue to receive additional doses as needed through the end of the treatment period (day 5)
Other Names:
|
Active Comparator: intravenous ibuprofen
|
800 mg intravenous ibuprofen diluted in 250 milliliters of normal saline was administered every 6 hours for a total of eight doses over the first 48 hours. Those patients who received the initial eight doses could continue to receive additional doses as needed through the end of the treatment period (day 5)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the Patient Demand for the Narcotic Analgesic, Morphine, Post Surgery
Time Frame: 24 Hours
|
Change in the amount of morphine use (in milligrams) by subjects in each treatment group for a 24 hour period post-surgery
|
24 Hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2005
Primary Completion (Actual)
January 1, 2008
Study Completion (Actual)
January 1, 2008
Study Registration Dates
First Submitted
September 22, 2005
First Submitted That Met QC Criteria
September 22, 2005
First Posted (Estimate)
September 26, 2005
Study Record Updates
Last Update Posted (Estimate)
June 22, 2016
Last Update Submitted That Met QC Criteria
May 17, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Ibuprofen
Other Study ID Numbers
- CPI-CL-008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
Clinical Trials on Intravenous ibuprofen
-
University of FloridaWithdrawnPatent Ductus Arteriosus
-
Hamad Medical CorporationRecruiting
-
Inonu UniversityCompletedPostoperative Pain ManagementTurkey
-
Inonu UniversityCompletedPostoperative Pain ManagementTurkey
-
Hopital La Rabtamaternity and neonatal centerCompleted
-
Bezmialem Vakif UniversityCompletedPostoperative Pain ManagementTurkey
-
University of PadovaSuspendedRespiratory Distress Syndrome | Ductus Arteriosus PatentItaly
-
Biomendi S.A.U.Pivotal S.L.Terminated
-
Anita GuptaCumberland PharmaceuticalsCompleted
-
University of California, Los AngelesSponsor Name PendingCompletedSymptomatic Uterine Fibroids and AdenomyosisUnited States